- Report
- March 2023
- 31 Pages
Global
From €4394EUR$4,995USD£3,813GBP
- Report
- March 2023
- 666 Pages
United States
From €7033EUR$7,995USD£6,103GBP
- Report
- December 2022
- 56 Pages
Global
From €4394EUR$4,995USD£3,813GBP
- Report
- June 2022
- 220 Pages
Global
From €3035EUR$3,450USD£2,633GBP
- Report
- April 2022
- 125 Pages
Global
€3387EUR$3,850USD£2,939GBP
- Report
- October 2021
- 70 Pages
United States
From €959EUR$1,090USD£832GBP
- Report
- April 2021
- 85 Pages
United States
From €1143EUR$1,299USD£992GBP
- Report
- January 2021
- 50 Pages
Global
€5000EUR$6,089USD£4,490GBP
- Report
- December 2020
- 200 Pages
Global
€3915EUR$4,450USD£3,397GBP
- Report
- August 2020
- 140 Pages
Global
€3990EUR$4,859USD£3,583GBP
- Report
- May 2018
- 106 Pages
Global
From €3079EUR$3,500USD£2,672GBP
- Report
- May 2018
South Korea
From €7033EUR$7,995USD£6,103GBP
- Report
- September 2025
China
From €1843EUR$2,095USD£1,599GBP
€3510EUR$3,990USD£3,046GBP
- Report
- September 2025
United States
From €1843EUR$2,095USD£1,599GBP
€3510EUR$3,990USD£3,046GBP
- Report
- September 2025
North America
From €1843EUR$2,095USD£1,599GBP
€3510EUR$3,990USD£3,046GBP
- Report
- September 2025
Middle East
From €1843EUR$2,095USD£1,599GBP
€3510EUR$3,990USD£3,046GBP
- Report
- September 2025
Asia Pacific
From €1843EUR$2,095USD£1,599GBP
€3510EUR$3,990USD£3,046GBP
- Report
- September 2025
Global
From €1843EUR$2,095USD£1,599GBP
€3510EUR$3,990USD£3,046GBP
- Report
- September 2025
Europe
From €1843EUR$2,095USD£1,599GBP
€3510EUR$3,990USD£3,046GBP
- Report
- September 2025
United Kingdom
From €1843EUR$2,095USD£1,599GBP
€3510EUR$3,990USD£3,046GBP

The Infusions and Injectables market is a segment of the pharmaceutical industry that focuses on the production and distribution of drugs that are administered through intravenous (IV) or intramuscular (IM) injections. These drugs are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases. The market is highly competitive, with a number of large pharmaceutical companies vying for market share.
The market is divided into two main segments: branded and generic drugs. Branded drugs are typically more expensive than generic drugs, but they are often more effective and have fewer side effects. Generic drugs are typically cheaper, but they may not be as effective or have as many side effects.
Some of the major players in the Infusions and Injectables market include Pfizer, Merck, Novartis, Sanofi, and Johnson & Johnson. These companies are responsible for the production and distribution of a wide range of drugs, including cancer treatments, diabetes medications, and autoimmune therapies. Show Less Read more